News tagged with pancreatic cancer

Related topics: cancer cells · cancer · pancreas · cancer research · patients

FDA approves new therapy for pancreatic cancer patients

Patients with advanced pancreatic cancer now have access to the new FDA approved drug, Onivyde, that produced significant overall survival rates in an international clinical study conducted in part by researchers at HonorHealth ...

Oct 26, 2015
popularity12 comments 0

Team studies point to clinical advantages of proton therapy

The search for evidence to support the growing use of proton therapy for more cancers at Penn Medicine continues to uncover valuable findings. New data from clinical trials conducted at the Robert Proton Therapy Center demonstrate ...

Oct 19, 2015
popularity62 comments 0

New drug targets the source of cancer renewal

A new class of drug that reduces cancer recurrence and spread may soon be available, with South Australian biopharmaceutical company Bionomics having passed review by the US Food and Drug Administration (FDA) with their product ...

Sep 25, 2015
popularity122 comments 0

Pancreatic cancer

Pancreatic cancer is a malignant neoplasm of the pancreas. Each year in the United States, about 42,470 individuals are diagnosed with this condition and 35,240 die from the disease. The prognosis is generally poor; less than 5 percent of those diagnosed are still alive five years after diagnosis. Complete remission is still extremely rare. About 95% of exocrine pancreatic cancers are adenocarcinomas (M8140/3). The remaining 5% include adenosquamous carcinomas, squamous cell carcinomas, and giant cell carcinomas. Exocrine pancreatic cancers are far more common than endocrine pancreatic cancers (islet cell carcinomas), which make up about 1% of total cases.

This text uses material from Wikipedia, licensed under CC BY-SA

Subscribe to rss feed